Search

everythinglearnresearchcommunity

for

Search:↓

Women with only irregular periods or excess hair have a better hormone profile than those with full PCOS, but both groups are similar, indicating a need for better PCOS diagnosis methods.

MPA improved hormonal imbalances and acne in women with PCOS without affecting metabolism.

Spironolactone is better than placebo for reducing excessive hair growth in women, but its effectiveness for acne is unclear due to small study sizes.

Spironolactone may help reduce hair growth and testosterone levels in some women with hirsutism.

Some medications can reduce excessive hair growth in women, but more research is needed to find the best treatment combinations.

The document concludes that managing hirsutism involves identifying the cause, using a scoring system for severity, combining cosmetic and medical treatments, encouraging weight loss, and providing psychological support, while noting the need for more research on drug treatments.

Flutamide combined with a low-dose birth control pill effectively reduces excessive hair growth in women with polycystic ovarian disease.

The document concludes that careful evaluation is needed to diagnose PCOS correctly due to similar symptoms in other conditions, and accurate testosterone level measurement is crucial.

Use good lighting, consistent positioning, and proper camera settings for effective hair disorder photos.

Prostate-specific antigen may be a new marker for excess male hormones in women with polycystic ovary syndrome.

Blood tests are needed to confirm high male hormone levels in women with PCOS, as physical signs alone are not reliable.

Testosterone increases hair growth and acne in transgender men.

Both treatments reduced excessive hair growth in PCOS, but there was no difference in weight, hair score, hormone levels, or insulin resistance.

The cream effectively reduces excessive hair growth and related skin issues without side effects.

Finasteride effectively reduces excess hair in women with certain conditions.

Excessive hair growth is much more common in Chinese women with PCOS than in the general population.

The FG score is better at detecting hyperandrogenism in PCOS patients than testosterone levels or FAI, but testosterone is the recommended test for diagnosis.

Women with PCOS have lower amylin levels, which are not related to their body weight.

The conclusion is that proper diagnosis and long-term treatment, including medication, hair removal, and lifestyle changes, are important for improving hirsutism, especially in PCOS patients.

The photographic method accurately measures hair growth and both treatments effectively reduced hair growth in hirsute women.

Women with PCOS are more likely to have depression and anxiety.

The review suggests a comprehensive approach to treat hirsutism, focusing on hair removal, medication, and managing emotional effects.

Higher androgen levels are linked to more severe hair growth in hirsute women.

Hirsutism and alopecia during menopause can be diagnosed and treated with specific hormonal and topical therapies.

Cheap treatments for excessive hair growth in women can improve symptoms by 35-40% after one year.

Canrenone effectively reduced hair growth and testosterone levels in women with excessive hairiness.

An unusual growth of Leydig cells in a woman's ovaries caused her excessive hair growth, which was treated successfully with surgery.

High Lipid Accumulation Product levels are linked to more hirsutism in women with Polycystic Ovary Syndrome.

The document concludes that proper diagnosis and individualized treatment are crucial for managing androgenization in women effectively.

Early menarche may indicate higher risk of severe hirsutism in PCOS patients.